As expected, R848@M2pep-MPsAFP or anti-PD-1 antibody treatment significantly inhibited tumor growth, with 72.9% and 43.1% inhibition in tumor weight (Fig. 6b, c), respectively. The gene discussed is PDCD1; the disease is neoplasm.